Erik de clercq (111 Ergebnisse)

Hardcover. Zustand: Wie neu. XI, 243 S.; Ill. Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 855.

Zustand: New.

Paperback. Zustand: new. Paperback. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,950grams, ISBN:0306416182. …

Zustand: New.

2004th ed. 15 x 23 cm. 254 pages. HC Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.

Zustand: As New. Unread book in perfect condition.

Zustand: As New. Unread book in perfect condition.

Zustand: New.

Zustand: New.

Zustand: As New. Unread book in perfect condition.

Zustand: New. pp. 392.

Zustand: New. pp. 320.

Hardcover. Zustand: Very Good. First Edition. Hardback. Ex-library with spine label, university and withdrawn stamps, cardholder, etc., corners bumped, else Very Good. No Dust Jacket.

Paperback. Zustand: Brand New. reprint edition. 322 pages. 9.61x6.69x0.73 inches. In Stock.

Paperback. Zustand: New. Chemistry at the Service of Medicine - Erik De Clercq *** [EN] Categories: Medicine | Condition: new | Binding: Paperback | Why exactly, chemistry and medicine? The author of this book, Prof. Erik De Clercq, presents in his lectures a wonderful world at the intersection of (bio)chemistry and modern medicine. He emphasized. *** [DE] Kategorien: Medizin | Zustand: neu | Einband: Taschenbuch | Warum genau, Chemie und Medizin? Der Autor dieses Buches, Prof. Erik De Clercq, präsentiert in seinen Vorlesungen eine wunderbare Welt an der Schnittstelle von (Bio-)Chemie und moderner Medizin. Er betonte. *** [CZ] Kategorie: Medicina | Stav: Novy | Proc presne, chemie a medicina? Autor teto knihy, prof. Erik De Clercq, ve svych prednaskach predstavuje nadherny svet na pomezi (bio)chemie a moderni mediciny. Zduraznil.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Antiviral Chemotherapy: An Introduction and Reasons for the Slow Progress, Particularly towards Rational Design.- Design of Nucleoside Analogs as Potential Antiviral Agents.- Design of Anti-Viral Agents other than Nucleoside Analogues.- Antivirals for High Hazards Viruses.- Human Retroviruses and Anti-Viral Therapies.- Epstein-Barr Virus.- Molecular Targets for Selective Antiviral Chemotherapy.- Inhibition of S-Adenosylmethionine-Dependent Transmethylation as an Approach to the Development of Antiviral Agents.- Assay Systems: Testing of Antiviral Drugs in Cell Culture (in vitro).- Animal Models as Assay Systems for the Development of Antivirals.- Experimental Aspects of Antiviral Pharmacology.- Virus Drug Resistance.- Interferon as an Antiviral Agent.- Risk-Benefit Analysis in Drug Research.- Safety Assessment of Antiviral Drugs.- Antiviral Agents: A New Beginning.- Participants.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This pUblication contains the Review Lectures presented at a joint NATO Advanced Study Institute and FEES Advanced Study Course held at Les Arcs, Bourg-8aint-Maurice, France, from the 19th June - 2nd July 1983. The Course, entitled 'Targets for the Design of Antiviral Agents' was in some ways a sequel to the NATO-FEES Course held at SOGESTA (near Urbino), Italy from the 7th - 18th May 1979 and published as volume A26 in this series. During the subsequent four years, we have witnessed the first of the 'new generation' of antiviral compounds, which are more efficacious and less toxic than the 'classical' antiviral drugs, reach the clinic and we felt that it w~s the right time to assess the future prospects of this verY important and exciting field. The vast majority of the drugs developed recently have proved active against various members of the herpesvirus family and elsewhere in this publication we learn that the cure for only rather few viral diseases, such as the common cold, influenza and herpes, promises the return on investment required by the pharmaceutical industry. However, the aim of this Course was for eminent virologists to identify possible targets among the various virus classes against which the chemists could then design suitable therapeutic agents. Recent advances with antiherpesvirus drugs have shown that a far greater selectivity and therapeutic index can be obtained than was previously thought to be possible.…

Zustand: New. Satisfaction Guaranteed or your money back.

Hardcover. Slight stain to lower RH edges, o/wise good condition in dj. Part of the NATO ASI series, Series A: Life Sciences Vol. 26. x, 459pp. ISBN 0306403021. 11436.

Paperback. Zustand: new. Paperback. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Hardcover. Good condition. No dj. Part of the NATO ASI series, Series A: Life Sciences Vol. 26. x, 459pp. ISBN 0306403021. 11436.

Hardcover. Zustand: New. Zustand des Schutzumschlags: Fine. 1st Edition. Plenum Press (1979). Hardcover, New unused book with small damage to the rear bottom of DJ. 10.1"x6.9"x1.4". be5x.

Paperback. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Zustand: As New. Unread book in perfect condition.

Zustand: New.

Zustand: New.

Zustand: New. Offers an extensive assessment of combination therapy of AIDS. In this book, the main focus is put on the Highly Active Antiretroviral Therapy (HAART) but other therapies like salvage therapy are also discussed. It also includes chapters that cover efficacy, treatment, causes of treatment failure, clinical care, guidelines, pharmacology. Editor(s): De Clercq, Erik; Vandamme, Anne-Mieke. Series: Milestones in Drug Therapy. Num Pages: 254 pages, biography. BIC Classification: MJCJ2. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 163 x 22. Weight in Grams: 532. . 2003. Hardback. . . . .…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - HIV infection has been a greater challenge to current medicine than any other viral disease ofmodem times. HIV leads to a persistent infection and the virus has an immense genetic flexibility under selective pressure. During its replica tive cycle in patients, HIV accumulates mutations at such a high rate that the selective pressure inflicted on the immune system, or generated by antiviral drugs rapidly triggers the appearance of escape mutants. Currently available drugs, when used singly, are not capable of suppressing virus replication in patients to such a level that the generation of mutations, from which a variant resistant to immune attack or antiviral drugs can be selected, is prevented. This is the main reason why combination therapy, usually of three drugs, has become the standard procedure for the treatment ofAIDS. It is obvious that virus eradication will not readily be achievable, so that drugs have to be taken for a prolonged time or even lifelong so as to keep the viral load as low as possible. Whether the currently used drug combinations will be able to control virus replication in a particular patient for such a pro longed period of time depends on many factors, most of which are addressed in the different chapters of this book. The aim of antiviral drug combination therapy for AIDS is ultimately to restore full function of the immune system. …

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - HIV infection has been a greater challenge to current medicine than any other viral disease ofmodem times. HIV leads to a persistent infection and the virus has an immense genetic flexibility under selective pressure. During its replica tive cycle in patients, HIV accumulates mutations at such a high rate that the selective pressure inflicted on the immune system, or generated by antiviral drugs rapidly triggers the appearance of escape mutants. Currently available drugs, when used singly, are not capable of suppressing virus replication in patients to such a level that the generation of mutations, from which a variant resistant to immune attack or antiviral drugs can be selected, is prevented. This is the main reason why combination therapy, usually of three drugs, has become the standard procedure for the treatment ofAIDS. It is obvious that virus eradication will not readily be achievable, so that drugs have to be taken for a prolonged time or even lifelong so as to keep the viral load as low as possible. Whether the currently used drug combinations will be able to control virus replication in a particular patient for such a pro longed period of time depends on many factors, most of which are addressed in the different chapters of this book. The aim of antiviral drug combination therapy for AIDS is ultimately to restore full function of the immune system.…